| Apyx Medical is an energy technology company. In its Advanced Energy segment, Co.'s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Co.'s primary focus is on the cosmetic surgery market where Renuvion® provides plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue. In its Original Equipment Manufacturing (OEM) segment, Co. produces generators and related accessories for medical device manufacturers through OEM agreements, as well as start-up companies with the need for its energy-based designs. We show 16 historical shares outstanding datapoints in our coverage of APYX's shares outstanding history.|
Understanding the changing numbers of APYX shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like APYX versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching APYX by allowing them to research APYX shares outstanding history
as well as any other stock in our coverage universe.